Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.77 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.54 |
| ▸ | LCK | P06239 | 1/20 | 0.54 |
| ▸ | FYN | P06241 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL305065 | 1.00 | TSHR (0.77) | TSHRFFAR3LCKFYNTP53 | |
| Cadaverine Tartrate SCHEMBL11877140 | 0.96 | TSHR (0.71) | TSHRFFAR3LCKFYNTP53 | |
| Cadaverine Tartrate SCHEMBL28125338 | 0.96 | TSHR (0.71) | TSHRFFAR3LCKFYNTP53 | |
| Cadaverine Tartrate SCHEMBL11052134 | 0.96 | TSHR (0.71) | TSHRFFAR3LCKFYNTP53 | |
| Cadaverine Tartrate SCHEMBL2085067 | 0.92 | TSHR (0.77) | TSHRFFAR3LCKFYNTP53 | |
| Cadaverine Tartrate SCHEMBL3972247 | 0.92 | TSHR (0.77) | TSHRFFAR3LCKFYNTP53 | |
| Cadaverine Tartrate SCHEMBL3972251 | 0.92 | TSHR (0.77) | TSHRFFAR3LCKFYNTP53 | |
| Cadaverine Tartrate SCHEMBL10709622 | 0.90 | TSHR (0.62) | TSHRFFAR3LCKFYNTP53 | |
| Cadaverine Tartrate SCHEMBL42202 | 0.89 | TSHR (0.71) | TSHRFFAR3LCKFYNTP53 | |
| Cadaverine Tartrate SCHEMBL10319920 | 0.89 | TSHR (0.71) | TSHRFFAR3LCKFYNTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106614888-A | Compounded enzyme preparation of tough biscuit and preparation method of compounded enzyme preparation | 四川新华扬山野生物有限公司 | 2017-05-10 | — | — | CN | claimed |
| CN-106509017-A | Special compound enzyme preparation for crisp biscuits and preparation method thereof | 武汉新华扬生物股份有限公司 | 2017-03-22 | — | — | CN | claimed |
| US-20260125620-A1 | AMPHOTERICALLY-MODIFIED TRIALKYLENE TETRAMINE ETHOXYLATES FOR IMPROVED STAIN REMOVAL OF LAUNDRY DETERGENTS | BASF SE (DE) | 2026-05-07 | — | — | US | disclosed |
| US-20260125623-A1 | PROCESS FOR MAKING A GRANULE OR POWDER CONTAINING A COMPLEXING AGENT | BASF SE (DE) | 2026-05-07 | — | — | US | disclosed |
| WO-2026087264-A1 | PROCESS FOR MAKING A POWDER OR GRANULE | BASF SE (DE) | 2026-04-30 | — | — | WO | disclosed |
| EP-4263777-B1 | BIODEGRADABLE POLYMERS | BASF SE (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4716735-A1 | SOLID DETERGENT FORMULATION | BASF SE (DE) | 2026-04-01 | — | — | EP | disclosed |
| EP-4716734-A1 | SOLID COMPOSITION COMPRISING AT LEAST ONE ORGANIC CHEMICAL COMPOUND AND AT LEAST ONE CERAMIC OXIDE | BASF SE (DE) | 2026-04-01 | — | — | EP | disclosed |
| US-20260078318-A1 | GRANULES OF MGDA AND (METH)ACRYLIC ACID HOMO- OR CO-POLYMER; PROCESS FOR MAKING THE SAME | BASF SE (DE) | 2026-03-19 | — | — | US | disclosed |
| EP-4705374-A1 | BIODEGRADABLE POLYOL PROPOXYLATES, THEIR PREPARATION, USES, AND COMPOSITIONS COMPRISING THEM | BASF SE (DE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4695321-A1 | VINYL ACETATE HAVING LOW DEUTERIUM CONTENT | BASF SE (DE) | 2026-02-18 | — | — | EP | disclosed |
| WO-2022136409-A1 | AMPHIPHILIC ALKOXYLATED POLYALKYLENE IMINES OR ALKOXYLATED POLYAMINES | BASF SE (DE) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022136408-A1 | NEW ALKOXYLATED POLYALKYLENE IMINES OR ALKOXYLATED POLYAMINES | BASF SE (DE) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022128684-A1 | BIODEGRADABLE POLYMERS | BASF SE (DE) | 2022-06-23 | — | — | WO | disclosed |
| US-20220154112-A1 | PROCESS FOR MAKING A GRANULE OR POWDER | BASF SE (DE) | 2022-05-19 | — | — | US | disclosed |
| EP-3947622-A1 | PROCESS FOR MAKING A GRANULE OR POWDER | BASF SE (DE) | 2022-02-09 | — | — | EP | disclosed |
| CN-113966383-A | Cleaning composition and use thereof | 巴斯夫欧洲公司 | 2022-01-21 | — | — | CN | disclosed |
| CN-106614888-A | Compounded enzyme preparation of tough biscuit and preparation method of compounded enzyme preparation | 四川新华扬山野生物有限公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-106509017-A | Special compound enzyme preparation for crisp biscuits and preparation method thereof | 武汉新华扬生物股份有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-106490178-A | A kind of coagulator made suitable for bean curd and preparation method thereof | 连云港日丰钙镁有限公司 | 2017-03-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078318-A1 | GRANULES OF MGDA AND (METH)ACRYLIC ACID HOMO- OR CO-POLYMER; PROCESS FOR MAKING THE SAME | SLC6A9, MVD, PGD | TSHR 3857/4885FFAR3 3838/4885LCK 3786/4885 |
| US-20260125620-A1 | AMPHOTERICALLY-MODIFIED TRIALKYLENE TETRAMINE ETHOXYLATES FOR IMPROVED STAIN REMOVAL OF LAUNDRY DETERGENTS | MPEG1, PHOSPHO1, EPN1 | TSHR 2393/4885FFAR3 3238/4885LCK 1169/4885 |
| US-20260125623-A1 | PROCESS FOR MAKING A GRANULE OR POWDER CONTAINING A COMPLEXING AGENT | SLC6A9, GGCT, SLC6A5 | TSHR 4299/4885FFAR3 4277/4885LCK 3900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.